P
Pakuwon Jati Tbk PT
IDX:PWON
Pakuwon Jati Tbk PT
IDX:PWON
Price:
394
IDR
Market Cap:
19T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
PWON Alert
Pakuwon Jati Tbk PT
394
0 (0%)
| 52 Week Range |
366
530
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Pakuwon Jati Tbk PT
Balance Sheet
Balance Sheet Decomposition
Pakuwon Jati Tbk PT
Pakuwon Jati Tbk PT
| Current Assets | 14.5T |
| Cash & Short-Term Investments | 8.9T |
| Receivables | 323.1B |
| Other Current Assets | 5.3T |
| Non-Current Assets | 20T |
| Long-Term Investments | 12.1T |
| PP&E | 2.8T |
| Other Non-Current Assets | 5T |
| Current Liabilities | 2.8T |
| Accounts Payable | 244.3B |
| Accrued Liabilities | 304.9B |
| Other Current Liabilities | 2.2T |
| Non-Current Liabilities | 11.4T |
| Long-Term Debt | 6T |
| Other Non-Current Liabilities | 5.4T |
Balance Sheet
Pakuwon Jati Tbk PT
Pakuwon Jati Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
2 809 034
|
2 071 164
|
2 432 451
|
3 406 223
|
4 460 081
|
4 313 285
|
2 886 903
|
6 443 643
|
7 172 145
|
7 599 820
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
326 231
|
|
| Cash Equivalents |
2 809 034
|
2 071 164
|
2 432 451
|
3 406 223
|
4 460 081
|
4 313 285
|
2 886 903
|
6 443 643
|
7 172 145
|
7 273 589
|
|
| Short-Term Investments |
0
|
0
|
16 500
|
0
|
0
|
66 050
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
303 348
|
301 528
|
237 296
|
523 043
|
532 085
|
934 481
|
238 329
|
251 676
|
228 613
|
262 089
|
|
| Accounts Receivables |
262 956
|
267 680
|
185 527
|
448 497
|
413 854
|
807 904
|
101 924
|
105 828
|
101 575
|
110 434
|
|
| Other Receivables |
40 392
|
33 849
|
51 769
|
74 546
|
118 231
|
126 577
|
136 406
|
145 848
|
127 038
|
151 655
|
|
| Inventory |
1 671 766
|
2 254 347
|
2 859 710
|
3 741 163
|
3 576 277
|
3 531 077
|
4 511 999
|
3 980 700
|
3 779 452
|
3 943 380
|
|
| Other Current Assets |
722 843
|
781 522
|
580 896
|
757 176
|
904 344
|
797 695
|
952 793
|
777 021
|
801 156
|
1 250 137
|
|
| Total Current Assets |
5 506 991
|
5 408 562
|
6 126 853
|
8 427 606
|
9 472 788
|
9 642 587
|
8 590 024
|
11 453 040
|
12 253 466
|
13 055 426
|
|
| PP&E Net |
1 496 721
|
2 745 646
|
1 830 614
|
1 981 087
|
1 867 657
|
2 233 295
|
2 366 089
|
2 340 702
|
2 353 620
|
2 728 000
|
|
| PP&E Gross |
1 496 721
|
2 745 646
|
1 830 614
|
1 981 087
|
1 867 657
|
2 233 295
|
2 366 089
|
2 340 702
|
2 353 620
|
2 728 000
|
|
| Accumulated Depreciation |
426 370
|
474 289
|
544 898
|
644 352
|
742 834
|
840 075
|
977 612
|
1 140 566
|
1 331 949
|
1 521 594
|
|
| Note Receivable |
18 615
|
67 272
|
67 272
|
22 505
|
17 848
|
17 848
|
17 848
|
5 708
|
5 708
|
1 869
|
|
| Long-Term Investments |
8 176 946
|
8 904 992
|
10 519 538
|
10 832 083
|
11 262 896
|
11 303 304
|
12 500 961
|
12 181 514
|
11 899 787
|
12 202 616
|
|
| Other Long-Term Assets |
1 571 469
|
1 651 650
|
2 129 865
|
2 095 437
|
2 396 891
|
2 898 119
|
2 983 883
|
2 885 117
|
4 089 599
|
4 722 875
|
|
| Total Assets |
16 770 743
N/A
|
18 778 122
+12%
|
20 674 142
+10%
|
23 358 718
+13%
|
25 018 080
+7%
|
26 095 153
+4%
|
26 458 805
+1%
|
28 866 081
+9%
|
30 602 180
+6%
|
32 710 787
+7%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
133 697
|
198 259
|
211 649
|
364 135
|
295 782
|
334 051
|
347 560
|
215 294
|
212 831
|
200 805
|
|
| Accrued Liabilities |
193 966
|
237 951
|
211 985
|
179 631
|
205 731
|
252 294
|
192 727
|
185 814
|
209 176
|
228 944
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
514 192
|
536 424
|
769 456
|
401 947
|
646 528
|
912 058
|
397 479
|
49 962
|
4 183
|
12 940
|
|
| Other Current Liabilities |
3 071 292
|
3 451 045
|
3 425 171
|
3 967 465
|
2 948 340
|
1 874 693
|
3 398 933
|
2 567 911
|
2 207 309
|
2 089 451
|
|
| Total Current Liabilities |
3 913 147
|
4 423 678
|
4 618 262
|
4 913 178
|
4 096 381
|
3 373 097
|
4 336 698
|
3 018 981
|
2 633 500
|
2 532 141
|
|
| Long-Term Debt |
4 104 692
|
4 392 844
|
4 475 899
|
5 025 599
|
4 933 665
|
3 884 632
|
3 546 539
|
5 656 871
|
6 272 709
|
6 145 209
|
|
| Deferred Income Tax |
0
|
22 560
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
2 109 995
|
2 236 051
|
2 335 946
|
2 471 924
|
2 715 563
|
3 124 279
|
2 963 216
|
3 131 733
|
3 410 649
|
3 698 755
|
|
| Other Liabilities |
447 899
|
483 985
|
560 287
|
628 450
|
676 353
|
741 782
|
976 873
|
1 011 791
|
977 695
|
1 238 103
|
|
| Total Liabilities |
10 597 667
N/A
|
11 559 117
+9%
|
11 990 394
+4%
|
13 039 152
+9%
|
12 421 962
-5%
|
11 123 789
-10%
|
11 823 326
+6%
|
12 819 376
+8%
|
13 294 553
+4%
|
13 614 208
+2%
|
|
| Equity | |||||||||||
| Common Stock |
1 203 990
|
1 203 990
|
1 203 990
|
1 203 990
|
1 203 990
|
1 203 990
|
1 203 990
|
1 203 990
|
1 203 990
|
1 203 990
|
|
| Retained Earnings |
4 608 954
|
5 654 568
|
7 122 129
|
8 778 191
|
11 032 103
|
13 414 519
|
13 062 775
|
14 445 323
|
15 791 520
|
17 583 692
|
|
| Additional Paid In Capital |
362 194
|
362 194
|
362 194
|
362 194
|
362 194
|
362 194
|
362 194
|
362 194
|
362 194
|
362 194
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
78 008
|
68 117
|
|
| Other Equity |
2 062
|
1 747
|
4 565
|
24 810
|
2 169
|
9 339
|
6 520
|
35 198
|
27 931
|
14 820
|
|
| Total Equity |
6 173 076
N/A
|
7 219 005
+17%
|
8 683 748
+20%
|
10 319 566
+19%
|
12 596 118
+22%
|
14 971 364
+19%
|
14 635 479
-2%
|
16 046 706
+10%
|
17 307 627
+8%
|
19 096 579
+10%
|
|
| Total Liabilities & Equity |
16 770 743
N/A
|
18 778 122
+12%
|
20 674 142
+10%
|
23 358 718
+13%
|
25 018 080
+7%
|
26 095 153
+4%
|
26 458 805
+1%
|
28 866 081
+9%
|
30 602 180
+6%
|
32 710 787
+7%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
48 160
|
48 160
|
48 160
|
48 160
|
48 160
|
48 160
|
48 160
|
48 160
|
48 160
|
48 160
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
